Medicines information factsheet developed for patients and the public

14 June 2016 - A new information factsheet providing information on how health care professionals decide what medicine is right for ...

Read more →

Two new films focus on how SMC works with patient groups

14 June 2016 - To help explain how it works with patient groups to capture and present the patient and carer ...

Read more →

Prostate cancer drug decision 'grossly unfair'

13 June 2016 - A charity has said it is "grossly unfair" that men with advanced prostate cancer in Scotland will ...

Read more →

SMC - June 2016 decisions

13 June 2016 - Treatments for Parkinson’s disease, advanced leukaemia and asthma among four new medicines accepted for routine use in ...

Read more →

SMC - May 2016 decisions

9 May 2016 - The SMC has today published advice accepting three new medicines for routine use in NHS Scotland. ...

Read more →

Patient group submissions to the SMC

21 April 2016 - The SMC has developed two short films to help explain how the agency works with patient groups ...

Read more →

SMC announces more forthcoming submissions

14 April 2016 - The SMC has announced forthcoming submissions for the following medicines: aflibercept (Eylea), alirocumab (Praluent), budesonide (Cortiment), diamorphine ...

Read more →

Updated new product assessment form and guidance

11 April 2016 - The SMC new product assessment form (NAPF) and guidance has been updated. ...

Read more →

SMC industry engagement event

12 April 2016 - The SMC are pleased to announce the date of the next industry engagement event. ...

Read more →

SMC - April 2016 decisions news release

11 April 2016 - SMC accepts three new medicines for routine use by NHS Scotland. ...

Read more →

Patients could suffer as drug costs threaten to bankrupt NHS

2 April 2016 - Patients may miss out on vital drugs as doctors warned that high costs could cause the health ...

Read more →

SMC allows wider use of Gedeon Richter's Esmya (ulipristal acetate)

23 March 2016 - The Scottish Medicines Consortium has approved funding for the use across NHS Scotland of a uterine fibroid ...

Read more →

SMC announces more forthcoming submissions

18 March 2016 - The SMC has announced forthcoming submissions for the following medicines: carfilzomib (Kyprolis), dasatinib monohydrate (Sprycel), emtricitabine with ...

Read more →

Scotland rejects cancer drugs Opdivo and Perjeta

7 March 2016 - The SMC has rejected Opdivo as a monotherapy for the treatment of advanced melanoma, and Perjeta for ...

Read more →

SMC - March 2016 decisions news release

7 March 2016 - The Scottish Medicines Consortium has today published advice accepting three new medicines for routine use in NHS ...

Read more →